{"result": {"id": "3d0ff255-20d2-436c-b005-1fa1c2c33b13", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "依洛尤单抗（Evolocumab）是一种PCSK9抑制剂，主要用于降低胆固醇水平。该药物通过抑制PCSK9蛋白的作用，有效减少低密度脂蛋白胆固醇（LDL-C）的浓度，从而帮助管理高胆固醇血症及相关心血管疾病风险。  \n\n依洛尤单抗的推荐剂量为140毫克，每两周一次，通过皮下注射给药。临床研究表明，该药物具有良好的安全性和耐受性，常见不良反应较轻，主要包括注射部位反应、鼻咽炎和上呼吸道感染等。  \n\n总体而言，依洛尤单抗是一种高效且耐受性良好的降胆固醇药物，适用于需要进一步降低LDL-C水平的患者，尤其是对他汀类药物反应不佳或不耐受的患者。", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752167342, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 150, "prompt_tokens": 179, "total_tokens": 329, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 115}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or more entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\nLimit the final description length to 500 words.\n\n#######\n-Data-\nEntities: \"依洛尤单抗\"\nDescription List: [\"Evolocumab, a PCSK9 inhibitor used for lowering cholesterol>\", \"PCSK9抑制剂，140 mg每2周1次皮下注射，安全性和耐受性好\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_2da93d7c5063200370a29c7b9d417c5dfb04216fadab25c8c17dda17f4ecf5bb_v2"}